Streetbeat News

GMVD

G Medical Innovations Holdings Limited

Industry

Surgical Appliance and Supplies Manufacturing

Open

0.16

Mkt cap

1.8M

Volume

2.2M

High

0.20

P/E Ratio

-0.01

52-wk high

13.82

Low

0.16

Div yield

N/A

52-wk low

0.14

In Wednesday's pre-market session, several healthcare stocks saw significant movement. Gainers included Novo Integrated Sciences (NVOS), MSP Recovery (LIFW), Sonnet BioTherapeutics (SONN), Precision BioSciences (DTIL), T2 Biosystems (TTOO), and Tivic Health Systems (TIVC). Losers included Impel Pharmaceuticals (IMPL), RVL Pharmaceuticals (RVLP), G Medical Innovations (GMVD), Oncternal Therapeutics (ONCT), Science 37 Hldgs (SNCE), and Taysha Gene Therapies (TSHA).

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:06 pm

The article lists the stocks that gained and lost the most during Tuesday's mid-day trading session. Notable gainers include Novo Integrated Sciences, Delcath Systems, and Tiziana Life Sciences, all of which saw significant jumps in their stock prices due to various positive developments. On the other hand, F45 Training Holdings, Design Therapeutics, and Galecto were among the biggest losers, with their stock prices falling due to various negative developments.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 6:01 pm

Several healthcare stocks experienced significant price movements during Tuesday's intraday session. Gainers included Delcath Systems, Novo Integrated Sciences, T2 Biosystems, Healthcare Triangle, Tiziana Life Sciences, and G Medical Innovations. Losers included Galecto, Design Therapeutics, Alaunos Therapeutics, Assure Hldgs, Bone Biologics, and OptimizeRx. Most of these movements were accompanied by unusually high trading volumes.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 5:31 pm

Several healthcare stocks experienced significant movement in Tuesday's pre-market session. Notable gainers included Delcath Systems (DCTH), Tiziana Life Sciences (TLSA), G Medical Innovations (GMVD), SCYNEXIS (SCYX), Taysha Gene Therapies (TSHA), and Evoke Pharma (EVOK). On the other hand, Galecto (GLTO), Design Therapeutics (DSGN), Alaunos Therapeutics (TCRT), OptimizeRx (OPRX), TFF Pharmaceuticals (TFFP), and PHAXIAM Therapeutics (PHXM) saw declines.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:06 pm

Delcath Systems, Inc. (DCTH) shares surged 57.7% after the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Sonim Technologies, Inc. (SONM) rose 29.1% after reporting a 125% revenue increase in Q2. F45 Training Holdings Inc. (FXLV) fell 62.7% after announcing its intent to voluntarily delist and deregister its securities. Altisource Asset Management Corporation (AAMC) shares fell 61.3% after posting a wider Q2 loss.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 12:17 pm

Several healthcare stocks experienced significant movement in Monday's after-market session. Cingulate, G Medical Innovations, Taysha Gene Therapies, Exicure, Arcellx, and Codexis saw gains, while Alaunos Therapeutics, Design Therapeutics, OptimizeRx, TFF Pharmaceuticals, Delcath Systems, and Acer Therapeutics experienced losses. Q2 earnings reports were released for several of these companies.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 9:32 pm

G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) has reported significant milestones and is on track for revenue growth and profitability. The company has seen growth in its monitoring services and is preparing to launch its 'At Home Test Kits' business unit. The company has also announced collaboration agreements with AdventHealth and Memorial Hermann Health Systems for its Remote Health Monitoring devices and services. The company is also planning to launch new products and services, including a blood pressure watch and Oxygen saturation watch, in Q4 2023.

Portfolio Pulse from Happy Mohamed

August 07, 2023 | 1:46 pm

On Friday, 73 companies reached new 52-week lows. Pfizer was the largest firm by market cap to set a new 52-week low, while INVO Bioscience was the smallest. Fangdd Network Group's shares dropped the most, while Harbor Custom Dev's stock rebounded the most.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:06 pm

The article lists the top 5 oversold health care stocks that could potentially rise in August. The stocks mentioned are BIOLASE, Inc. (BIOL), G Medical Innovations Holdings Ltd (GMVD), Allarity Therapeutics, Inc. (ALLR), ZyVersa Therapeutics, Inc. (ZVSA), and Penumbra, Inc. (PEN). The stocks are considered oversold as their Relative Strength Index (RSI) is near or below 30.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 3:12 pm

During Friday's intraday session, several health care stocks experienced significant movements. Gainers included Reata Pharmaceuticals (RETA), Homology Medicines (FIXX), Bluejay Diagnostics (BJDX), Gracell Biotechnologies (GRCL), Pulse Biosciences (PLSE), and Larimar Therapeutics (LRMR). Losers included Tonix Pharmaceuticals (TNXP), Mallinckrodt (MNK), Intelligent Bio Solutions (INBS), G Medical Innovations (GMVD), Femasys (FEMY), and Marker Therapeutics (MRKR).

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.